BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 1, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 11, 2009
View Archived Issues
Novel inhibitors of MDM2 and p53 interaction claimed by Janssen Pharmaceutica
Read More
GlaxoSmithKline claims quinoxaline derivatives as PI3 kinase inhibitors
Read More
Novel androgen receptor agonists developed by Takeda
Read More
Novel non-nucleoside reverse transcriptase inhibitors claimed by GlaxoSmithKline
Read More
Organon claims TRVP1 modulators for treatment of pain
Read More
Schering-Plough presents novel alpha2C adrenoreceptor agonists
Read More
Vertex recaps year's events
Read More
AFFIRM data show high rate of relapsing-remitting multiple sclerosis remission with natalizumab
Read More
Mymetics to acquire Virosome Biologicals and expand vaccine portfolio
Read More
EC designates KNS-760704 as orphan medicinal product for ALS
Read More
Avexa and Progen terminate proposed merger agreement
Read More
GlaxoSmithKline identifies a novel EP1 receptor antagonist for the treatment of inflammatory pain
Read More
Mepact receives E.U. approval for non-metastatic resectable osteosarcoma
Read More
AVEO initiates phase Ib/IIa trial for AV-951 in non-small cell lung cancer
Read More
FDA grants orphan drug designation to Eurand's EUR-1073 for ulcerative colitis
Read More
Raloxifene does not affect the incidence of coronary events in postmenopausal women
Read More
Identification of the CR-6261 epitope may help rational vaccine design for influenza A
Read More
Generex Biotechnology presents successful phase III data for Generex Oral-lyn
Read More
Intra-Cellular Therapies reports final results for phase II ITI-007 trial
Read More
Solasia initiates clinical development of its first drug in Japan
Read More
Synosia enters second agreement with Roche for new-generation 5-HT6 antagonist
Read More
NCI to conduct in vitro and in vivo studies of Azaya's cancer drug ATI-1123
Read More
Sunesis sells LFA-1 inhibitor program to SARcode for USD 2 million
Read More
Tolerx initiates enrollment in phase III DEFEND trial of otelixizumab in Europe
Read More
